Methods and monitoring of treatment with a WNT pathway inhibitor Grant US-9987357-B2 United States of America 05 Jun 2018
Compositions and methods for diagnosing and treating cancer Grant US-9850311-B2 United States of America 26 Dec 2017
Methods of treating cancer by administering a soluble receptor comprising a human Fc… Grant US-9732139-B2 United States of America 15 Aug 2017
Wnt antagonist and methods of treatment and screening Grant US-9579361-B2 United States of America 28 Feb 2017
Methods and monitoring of treatment with a Wnt pathway inhibitor Grant US-9359444-B2 United States of America 07 Jun 2016
Methods of treating neuroendocrine tumors using frizzled-binding agents Grant US-9266959-B2 United States of America 23 Feb 2016
Methods of using the FRI domain of human frizzled receptor for inhibiting Wnt signaling… Grant US-9228013-B2 United States of America 05 Jan 2016
Wnt antagonists and methods of treatment and screening Grant US-9157904-B2 United States of America 13 Oct 2015
Polynucleotides encoding for frizzled-binding agents and uses thereof Grant US-8975044-B2 United States of America 10 Mar 2015
Human frizzled (FZD) receptor polypeptides and methods of use thereof for treating cancer… Grant US-8765913-B2 United States of America 01 Jul 2014
Frizzled-binding agents and their use in screening for WNT inhibitors Grant US-8551789-B2 United States of America 08 Oct 2013
Methods of use for an antibody against human frizzled receptors 1, 2. 5, 7 or 8 Grant US-8507442-B2 United States of America 13 Aug 2013
Nucleic acid molecules encoding soluble frizzled (FZD) receptors Grant US-8324361-B2 United States of America 04 Dec 2012
FRIZZLED-BINDING AGENTS AND USES THEREOF Application WO-2010037041-A3 World Intellectual Property Organisation (WIPO) 13 Jan 2011